AzTrials
AzTrials

Language DelayPhase 3NCT00625261

Effectiveness of Early Parent-Based Language Intervention

A Phase 3 study testing Heidelberg Parent-based Language Intervention HPLI in people with Language Delay and Developmental Language Disorders, run by Heidelberg University at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of the study is to examine the effectiveness of a highly-structured parent-based language intervention group program for two-year-old children with language delay. Read more about this study

Who is it for?
Ages 24 to 27 months
What is being tested?
Heidelberg Parent-based Language Intervention HPLI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteGermany
Study dates
Oct 2003to Oct 2011
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 27 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children with receptive and/or expressive language abilities below norm range measured by the standardized and norm-referenced German developmental language test SETK-2 (Grimm, 2000)

Who cannot join

  • Children with visual impairments, genetic syndromes, metabolic diseases
  • Children with previous language intervention

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Department of Pediatric Neurology, Childrens Hospital, University of Heidelberg

    Heidelberg, D-69120

Other trials in Germany

About this study

Official title: Effectiveness of a Parent-Based Language Intervention Group Program for Two-Year-Old Children With Language Delay

The purpose of the study is to examine the effectiveness of a highly-structured parent-based language intervention group program for two-year-old children with language delay.

Read the detailed description

Language delay in toddlers is a prevalent problem for pediatric practitioners. As there are no clear guidelines to deal with this problem, in German speaking countries the "wait-and-see"approach is widely chosen, although longitudinal studies have found that children with language delay are at risc for cognitive, behavioral and social-emotional problems.

During the last few years various forms of early language intervention have been increasingly implemented in German speaking countries. However, they have not been evaluated.

Early parent-based intervention could be an economical way in prevention speech and language disorders.

Being tested
Heidelberg Parent-based Language Intervention HPLI
Keywords
Language delay, Speech and language disorders, Early language intervention, Parent-based language intervention
Medical subject headings
Language Development Disorders, Speech, Language Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heidelberg Parent-based Language Intervention HPLIOther

    Also called Early language intervention

    The HPLI is a group program for parents of young children with language delay. This 12-14week program includes seven two-our sessions and one three-our session six months later. It is designed for 5 to 10 people and based of an interactive model of language intervention, wich presumes that optimized parental input will provide better language-learning opportunities.

Study groups in NCT00625261
Study groupRoleWhat they receive
1ExperimentalThe mothers of the two-years old children in the intervention group took part at the Heidelberg Parent-based Language Intervention HPLI
Receives: Other: Heidelberg Parent-based Language Intervention HPLI
2No interventionWaiting group, no intervention until children were three years of age

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Receptive and expressive language abilities using standardized instruments (SETK-2, SETK 3-5, AWST, HVS, HASE, HSET)

    Measured: at 2; 6, 3, 4, 5 and 8 years of age

Secondary outcomes (1)
  1. Parent-report screening questionnaire ELFRA-2 (adoption of the MacArthur Communicative Development Inventories-CDI); cognitive and social-emotional development assessed by standardized instruments,

    Measured: at 2;6, 3, 4, 5 and 8 years of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2008 (estimated)
  2. Study startOct 2003
  3. Primary completionFeb 2008
  4. Study completionOct 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00625261
Sponsor's protocol ID
243/2002
Status last verified
Aug 2007
First submitted
19 Feb 2008
Last updated
28 Feb 2008
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Heidelberg Parent-based Language Intervention HPLI in people with Language Delay and Developmental Language Disorders, run by Heidelberg University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Feb 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Receptive and expressive language abilities using standardized instruments (SETK-2, SETK 3-5, AWST, HVS, HASE, HSET) (time frame: at 2; 6, 3, 4, 5 and 8 years of age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2008.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in